Abstract:
Ameloblastoma is a locally aggressive benign tumor affecting the jaw bones accounting for 1% of all oral tumors. However owing to their high recurrence rate and locally aggressive behaviour, the most common method of treatment employed is resection followed by various modalities of reconstruction. Similarly Odontogenic keratocysts are benign cystic lesion affecting the jaw bones accounting for about 5-10% of all cyst and with high recurrence rate. In this study we evaluated 20 young patients with Odontogenic keratocyst and ameloblastoma. The modality of treatment was conservative by enucleation and iodoform packing. The pack was changed every 1 week for 3 months and follow up was done clinically and radiographically for 8 years. There was uneventful healing and bone regeneration with no evidence of recuurence. Most the cases, included in our study were children less than 12 years of age. For them resection is an aggressive procedure which results in severe deformity all throughout their life. Although there is need for long term follow up, we were able to conserve the patient’s own bone during the growth period.
Biography:
Dr. Anu Jose stands as a preeminent figure in contemporary oral and maxillofacial surgery, distinguished by her groundbreaking contributions to oncological surgery and innovative reconstruction techniques. Currently serving dual leadership roles at prestigious institutions, Dr. Anu Jose practices as a Facio-Maxillary Surgeon at The University Hospital of the West Indies, Kingston, Jamaica, and as an Oral and Maxillofacial Oncologist at FOSA Surgical Associates. These appointments reflect her exceptional clinical capabilities and institutional confidence in her expertise. Her Fellowship in Oral Oncology from the distinguished SGM Cancer Center has equipped her with unparalleled expertise in managing complex head and neck malignancies. Her surgical repertoire encompasses the most sophisticated procedures in oncological surgery, including radical tumor resections, comprehensive neck dissections, and advanced microvascular reconstruction utilizing free tissue transfer techniques. Dr. Jose's intellectual contributions to the field are substantiated by her impressive portfolio of over 28 peer-reviewed publications in prestigious journals indexed within PubMed and Scopus databases. Her research addresses critical areas of clinical relevance, with particular emphasis on oncological outcomes, reconstructive innovations, and evidence-based surgical protocols. Her scholarly work demonstrates a rare combination of clinical insight and research acumen, consistently addressing real-world challenges while contributing to the theoretical framework underlying contemporary oral and maxillofacial surgery practice. Dr. Jose's expertise has transcended geographical boundaries through her active participation as a distinguished speaker at numerous national and international conferences worldwide. Her presentations consistently showcase innovative surgical techniques, novel research methodologies, and evidence-based approaches to complex clinical scenarios. Her approach to medical practice reflects a deep appreciation for cultural sensitivity and international collaboration—understanding that the pursuit of medical excellence requires both technical mastery and respectful engagement with diverse healthcare traditions. This philosophy of harmonious integration between innovation and respect for established wisdom has positioned her as a valued contributor to global medical discourse.
